402 related articles for article (PubMed ID: 16837438)
1. Potential of cranberry-based herbal synergies for diabetes and hypertension management.
Apostolidis E; Kwon YI; Shetty K
Asia Pac J Clin Nutr; 2006; 15(3):433-41. PubMed ID: 16837438
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension.
Kwon YI; Jang HD; Shetty K
Asia Pac J Clin Nutr; 2006; 15(3):425-32. PubMed ID: 16837437
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension.
Kwon YI; Vattem DA; Shetty K
Asia Pac J Clin Nutr; 2006; 15(1):107-18. PubMed ID: 16500886
[TBL] [Abstract][Full Text] [Related]
4. Potential of cranberry powder for management of hyperglycemia using in vitro models.
Pinto Mda S; Ghaedian R; Shinde R; Shetty K
J Med Food; 2010 Oct; 13(5):1036-44. PubMed ID: 20626248
[TBL] [Abstract][Full Text] [Related]
5. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.
McCue P; Kwon YI; Shetty K
Asia Pac J Clin Nutr; 2005; 14(2):145-52. PubMed ID: 15927931
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.
Deo P; Hewawasam E; Karakoulakis A; Claudie DJ; Nelson R; Simpson BS; Smith NM; Semple SJ
BMC Complement Altern Med; 2016 Nov; 16(1):435. PubMed ID: 27809834
[TBL] [Abstract][Full Text] [Related]
7. Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro.
Ademiluyi AO; Oboh G
Exp Toxicol Pathol; 2013 Mar; 65(3):305-9. PubMed ID: 22005499
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antihyperglycemia and antihypertension potential of native Peruvian fruits using in vitro models.
Pinto Mda S; Ranilla LG; Apostolidis E; Lajolo FM; Genovese MI; Shetty K
J Med Food; 2009 Apr; 12(2):278-91. PubMed ID: 19459727
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory activity on type 2 diabetes and hypertension key-enzymes, and antioxidant capacity of Veronica persica phenolic-rich extracts.
Sharifi-Rad M; Tayeboon GS; Sharifi-Rad J; Iriti M; Varoni EM; Razazi S
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):80-5. PubMed ID: 27262808
[TBL] [Abstract][Full Text] [Related]
10. Varietal influences on antihyperglycemia properties of freshly harvested apples using in vitro assay models.
Barbosa AC; Pinto Mda S; Sarkar D; Ankolekar C; Greene D; Shetty K
J Med Food; 2010 Dec; 13(6):1313-23. PubMed ID: 20874247
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase.
Adisakwattana S; Ruengsamran T; Kampa P; Sompong W
BMC Complement Altern Med; 2012 Jul; 12():110. PubMed ID: 22849553
[TBL] [Abstract][Full Text] [Related]
12. Profiles of free and bound phenolics extracted from Citrus fruits and their roles in biological systems: content, and antioxidant, anti-diabetic and anti-hypertensive properties.
Alu'datt MH; Rababah T; Alhamad MN; Al-Mahasneh MA; Ereifej K; Al-Karaki G; Al-Duais M; Andrade JE; Tranchant CC; Kubow S; Ghozlan KA
Food Funct; 2017 Sep; 8(9):3187-3197. PubMed ID: 28805834
[TBL] [Abstract][Full Text] [Related]
13. Phenolic-rich extracts from selected tropical underutilized legumes inhibit α-amylase, α-glucosidase, and angiotensin I converting enzyme in vitro.
Ademiluyi AO; Oboh G
J Basic Clin Physiol Pharmacol; 2012 Jan; 23(1):17-25. PubMed ID: 22865445
[TBL] [Abstract][Full Text] [Related]
14. Effect of sprouting on antioxidant and inhibitory potential of two varieties of Bengal gram (Cicer arietinum L.) against key enzymes linked to type-2 diabetes.
Prathapan A; Fahad K; Thomas BK; Philip RM; Raghu KG
Int J Food Sci Nutr; 2011 May; 62(3):234-8. PubMed ID: 21126210
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies of Gynura divaricata (L.) DC extracts as inhibitors of key enzymes relevant for type 2 diabetes and hypertension.
Wu T; Zhou X; Deng Y; Jing Q; Li M; Yuan L
J Ethnopharmacol; 2011 Jun; 136(2):305-8. PubMed ID: 21570455
[TBL] [Abstract][Full Text] [Related]
16. Enzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemia.
Gulati V; Harding IH; Palombo EA
BMC Complement Altern Med; 2012 Jun; 12():77. PubMed ID: 22713130
[TBL] [Abstract][Full Text] [Related]
17. Phenolic-linked variation in strawberry cultivars for potential dietary management of hyperglycemia and related complications of hypertension.
Cheplick S; Kwon YI; Bhowmik P; Shetty K
Bioresour Technol; 2010 Jan; 101(1):404-13. PubMed ID: 19695871
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant, α-Amylase and α-Glucosidase Inhibitory Activities and Potential Constituents of
Quan NV; Xuan TD; Tran HD; Thuy NTD; Trang LT; Huong CT; Andriana Y; Tuyen PT
Molecules; 2019 Feb; 24(3):. PubMed ID: 30744084
[TBL] [Abstract][Full Text] [Related]
19. Shaddock peels (Citrus maxima) phenolic extracts inhibit α-amylase, α-glucosidase and angiotensin I-converting enzyme activities: a nutraceutical approach to diabetes management.
Oboh G; Ademosun AO
Diabetes Metab Syndr; 2011; 5(3):148-52. PubMed ID: 22813568
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory Effects of Siegesbeckia orientalis Extracts on Advanced Glycation End Product Formation and Key Enzymes Related to Metabolic Syndrome.
Hung WC; Ling XH; Chang CC; Hsu HF; Wang SW; Lee YC; Luo C; Lee YT; Houng JY
Molecules; 2017 Oct; 22(10):. PubMed ID: 29065451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
